Rituxan 50242-0051
Generic: Rituximab
Product NDC
50242-0051- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 26, 1997
- Listing Expires
- December 31, 2026
- Application
- BLA103705
Need to source Rituxan? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rituximab | 10 mg/mL |
Drug Class
CD20-directed Cytolytic Antibody [EPC]CD20-directed Antibody Interactions [MoA]CD20-directed Cytolytic Antibody [EPC]
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 CARTON (50242-051-21) / 10 mL in 1 VIAL, SINGLE-USE